ProfileGDS4718 / 228529_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 36% 67% 48% 54% 53% 43% 48% 47% 52% 39% 59% 42% 48% 56% 38% 58% 36% 56% 45% 48% 54% 51% 58% 49% 62% 61% 71% 43% 41% 29% 69% 47% 30% 45% 43% 47% 42% 45% 70% 48% 46% 49% 36% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0357841
GSM549102patient 115, normal, homogenized [OPG study]4.8141936
GSM549104patient 119, normal, homogenized [OPG study]6.6483367
GSM549108patient 138, normal, homogenized [OPG study]5.4469748
GSM549119patient 077, normal, homogenized [OPG study]5.7673954
GSM549133patient 032, cancer, homogenized [OPG study]5.6503753
GSM549139patient 042, cancer, homogenized [OPG study]5.0966743
GSM549099patient 107, normal, homogenized [OPG study]5.4308448
GSM549109patient 139, normal, homogenized [OPG study]5.3819947
GSM549110patient 046, normal, homogenized [OPG study]5.6020952
GSM549114patient 063, normal, homogenized [OPG study]4.8857839
GSM549122patient 082, normal, homogenized [OPG study]6.0591859
GSM549134patient 033, cancer, homogenized [OPG study]5.0818942
GSM549136patient 036, cancer, homogenized [OPG study]5.3607448
GSM549140patient 044, cancer, homogenized [OPG study]5.8682456
GSM549111patient 047, normal, homogenized [OPG study]4.8887138
GSM549113patient 057, normal, homogenized [OPG study]5.9906158
GSM549132patient 031, cancer, homogenized [OPG study]4.8049936
GSM549137patient 038, cancer, homogenized [OPG study]5.852956
GSM549142patient 047, cancer, homogenized [OPG study]5.3959645
GSM549100patient 110, normal, homogenized [OPG study]5.4129848
GSM549107patient 135, normal, homogenized [OPG study]5.7361354
GSM549115patient 068, normal, homogenized [OPG study]5.538151
GSM549116patient 072, normal, homogenized [OPG study]5.9897858
GSM549120patient 078, normal, homogenized [OPG study]5.4666949
GSM549131patient 030, cancer, homogenized [OPG study]6.2698262
GSM549118patient 074, normal, homogenized [OPG study]6.1936661
GSM549129patient 027, cancer, homogenized [OPG study]7.0275471
GSM549123patient 088, normal, homogenized [OPG study]5.1207443
GSM549124patient 006, cancer, homogenized [OPG study]5.0682641
GSM549126patient 015, cancer, homogenized [OPG study]4.4721129
GSM549128patient 025, cancer, homogenized [OPG study]6.8792169
GSM549103patient 117, normal, homogenized [OPG study]5.4188547
GSM549117patient 073, normal, homogenized [OPG study]4.5126330
GSM549138patient 041, cancer, homogenized [OPG study]5.2178145
GSM549141patient 045, cancer, homogenized [OPG study]5.0704843
GSM549130patient 028, cancer, homogenized [OPG study]5.3533347
GSM549101patient 111, normal, homogenized [OPG study]5.120142
GSM549105patient 128, normal, homogenized [OPG study]5.2473445
GSM549106patient 134, normal, homogenized [OPG study]6.9384670
GSM549112patient 048, normal, homogenized [OPG study]5.3679248
GSM549125patient 011, cancer, homogenized [OPG study]5.3179546
GSM549127patient 024, cancer, homogenized [OPG study]5.4436549
GSM549135patient 035, cancer, homogenized [OPG study]4.7619836